Vaishali Pharma Limited
Vaishali Pharma Limited (VAISHALI) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
vaishalipharma.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Sales | 32 Cr | 24 Cr | 33 Cr | 25 Cr | 27 Cr | 23 Cr |
| Operating expenses (approx.) | 38 Cr | 22 Cr | 32 Cr | 23 Cr | 27 Cr | 21 Cr |
| EBITDA | -6 Cr | 1 Cr | 1 Cr | 2 Cr | -0.20 Cr | 1 Cr |
| OPM % | -18.7% | 5.8% | 4.2% | 6.3% | -0.8% | 6.5% |
| Other income | 1 Cr | 0.84 Cr | 0.84 Cr | 0.89 Cr | 1 Cr | 0.58 Cr |
| Interest | 0.44 Cr | 0.33 Cr | 0.40 Cr | 0.51 Cr | 0.72 Cr | 0.20 Cr |
| Depreciation | 0.12 Cr | 0.14 Cr | 0.17 Cr | 0.13 Cr | 0.16 Cr | 0.14 Cr |
| Profit before tax | -6 Cr | 2 Cr | 2 Cr | 2 Cr | 0.29 Cr | 2 Cr |
| Tax % | 23.4% | 26.3% | 28.4% | 28.1% | -29.5% | 13.6% |
| Net profit | -4 Cr | 1 Cr | 1 Cr | 1 Cr | 0.38 Cr | 2 Cr |
| EPS (₹) | ₹-3.17 | ₹0.10 | ₹0.09 | ₹0.10 | ₹0.03 | ₹0.12 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 99 Cr | 109 Cr | Sign in for TTM |
| Operating expenses (approx.) | 99 Cr | 105 Cr | Sign in for TTM |
| EBITDA | 0.09 Cr | 4 Cr | Sign in for TTM |
| OPM % | 0.1% | 3.8% | Sign in for TTM |
| Other income | 3 Cr | 4 Cr | Sign in for TTM |
| Interest | 2 Cr | 2 Cr | Sign in for TTM |
| Depreciation | 0.49 Cr | 0.60 Cr | Sign in for TTM |
| Profit before tax | 1 Cr | 6 Cr | Sign in for TTM |
| Tax % | 33.3% | 24.6% | Sign in for TTM |
| Net profit | 0.82 Cr | 4 Cr | Sign in for TTM |
| EPS (₹) | ₹0.31 | ₹0.32 | Sign in for TTM |
| Dividend payout % | 0.0% | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 26 Cr | 26 Cr |
| Reserves | 39 Cr | 43 Cr |
| Borrowings | 12 Cr | 19 Cr |
| Other liabilities | 33 Cr | 36 Cr |
| Total liabilities | 110 Cr | 123 Cr |
| Fixed assets (net) | 0.65 Cr | 0.90 Cr |
| CWIP | 0 Cr | 0.25 Cr |
| Investments | 1 Cr | 6 Cr |
| Inventories | 5 Cr | 3 Cr |
| Trade receivables | 47 Cr | 51 Cr |
| Cash & bank | 2 Cr | 1 Cr |
| Other assets | 55 Cr | 61 Cr |
| Total assets | 110 Cr | 123 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | -18 Cr | — |
| Cash from investing | -0.19 Cr | — |
| Cash from financing | 18 Cr | — |
| Net cash flow | 0.26 Cr | — |
| Free cash flow (OCF − Capex) | -18 Cr | — |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 3.7% | 8.5% |
| ROE % | 1.3% | 6.0% |
| Debtor days | 172 | 170 |
| Inventory days | 18 | 11 |
| Days payable | 100 | 71 |
| Cash conversion cycle | 90 | 110 |
| Debt / equity | 0.18 | 0.27 |
| Current ratio | 2.61 | 2.34 |
| Net debt / EBITDA | 110.54 | 4.23 |